Last week, the Senate confirmed Robert Califf to run the FDA by a narrow vote of 50-46. Califf had previously served as the FDA Commissioner in the final months of Obama’s presidency before Janet Woodcock took over as interim chief. After a 13-month holding pattern, placing Califf as a permanent leader will hopefully bring some stability to the agency. A recent POLITICO article (well worth reading the full article) discussed 6 challenges that await Califf as he takes the reins. The include:
6 Challenges Facing the New FDA Commissioner
Robert Califf returns to a permanent position, but the political landscape has changed a lot since he last acted as Commissioner.
Feb 18, 2022
Recommended
Recommended
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
